HER STYLE Drug Patent Profile
Which patents cover Her Style, and when can generic versions of Her Style launch?
Her Style is a drug marketed by Novast Labs and is included in one NDA.
The generic ingredient in HER STYLE is levonorgestrel. There is one drug master file entry for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the levonorgestrel profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Her Style
A generic version of HER STYLE was approved as levonorgestrel by NOVEL LABS INC on February 22nd, 2013.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for HER STYLE?
- What are the global sales for HER STYLE?
- What is Average Wholesale Price for HER STYLE?
Summary for HER STYLE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 112 |
| Patent Applications: | 3,947 |
| Drug Prices: | Drug price information for HER STYLE |
| DailyMed Link: | HER STYLE at DailyMed |
Pharmacology for HER STYLE
| Drug Class | Progestin Progestin-containing Intrauterine System |
| Physiological Effect | Inhibit Ovum Fertilization |
US Patents and Regulatory Information for HER STYLE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novast Labs | HER STYLE | levonorgestrel | TABLET;ORAL | 207976-001 | Mar 11, 2016 | OTC | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
